|
|
|
|
|
|
|
|
|
06.07.26 - 23:06
|
Vertex To Acquire Crinetics Pharma For $10 Bln (AFX)
|
|
|
CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals (VRTX) said Monday it has agreed to acquire Crinetics Pharmaceuticals (CRNX) in an all-cash deal valued at approximately $10 billion, s......
|
|
|
|
|
|
|
|
|
|
|
06.07.26 - 22:06
|
Vertex to Acquire Crinetics Pharmaceuticals (Business Wire)
|
|
|
- Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex's portfolio -
- PALSONIFY®, Crinetics' recently launched, first and only, once-daily oral therapy for adults with acromegaly has demonstrated strong and growing early uptake -
- Atumelnant, a once-daily oral adrenocorticotropic hormone (ACTH) receptor antagonist in Phase 3 development for congenital adrenal hyperplasia (CAH), has shown unique and transformative potential to both normalize androgen levels and enable management of patients with physiologic levels of glucocorticoids, the true goal of CAH management; atumelnant has also demonstrated therapeutic potential in patients with Cushing's syndrome -
- Acquisition adds to Vertex's innovation pipeline, accelerates Vertex's revenue growth and enhances long-term earnings profile -
- Vertex to host investor call today, July 6 at 4:30 p.m. ET -BOSTON & SAN DIEGO--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporate...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
